Does PEMBROLIZUMAB Cause Dermatitis allergic? 35 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Dermatitis allergic have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.0% of all adverse event reports for PEMBROLIZUMAB.
35
Reports of Dermatitis allergic with PEMBROLIZUMAB
0.0%
of all PEMBROLIZUMAB reports
1
Deaths
19
Hospitalizations
How Dangerous Is Dermatitis allergic From PEMBROLIZUMAB?
Of the 35 reports, 1 (2.9%) resulted in death, 19 (54.3%) required hospitalization.
Is Dermatitis allergic Listed in the Official Label?
Yes, Dermatitis allergic is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Dermatitis allergic?
ADALIMUMAB (889)
DUPILUMAB (818)
METHOTREXATE (541)
ETANERCEPT (508)
ABATACEPT (322)
TOCILIZUMAB (271)
LENALIDOMIDE (247)
RITUXIMAB (194)
LEFLUNOMIDE (173)
INFLIXIMAB (171)
Which PEMBROLIZUMAB Alternatives Have Lower Dermatitis allergic Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G